System Chief of Hematologic Malignancies Northwell Health Cancer Institute seeks a visionary physician leader to serve as the inaugural System Chief of Hematologic Malignancies. This landmark role is designed to advance and expand our hematologic oncology research programs across one of the nation's most dynamic health systems. The role aligns with the Institute’s mission to break through geographic, socioeconomic, and access barriers, ensuring that people receive state‑of‑the‑art, compassionate cancer care with access to cutting‑edge investigational therapies. Responsibilities: Design and implement a cohesive system‑wide strategy for hematologic malignancies. Establish disease‑specific centers of excellence with dedicated multidisciplinary teams for lymphoma (Hodgkin and Non‑Hodgkin), leukemia (Acute and Chronic — ALL, AML, CLL, CML), multiple myeloma and plasma cell disorders. Collaborate with cellular‑therapy and bone‑marrow transplant programs to create a seamless continuum of care from diagnosis through survivorship. Drive a Bold Research Agenda Establish and fortify a robust clinical trials infrastructure for hematologic malignancies, including early‑phase (Phase I/II) investigator‑initiated studies. Recruit and mentor physician‑scientists to build translational and clinical research portfolios. Pursue NCI designation contributions through scholarly output, grant funding, and programmatic development. Focus on Academia Foster a culture of academic excellence. Develop the next generation of leaders through medical education, fellowship training, and mentorship programs. Partner with the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell to advance educational and academic mission. Qualifications MD or MD/PhD from an accredited institution. Board certification in hematology and/or medical oncology. Significant clinical expertise and national/international reputation in one or more areas of hematologic malignancies (lymphoma, leukemia, myeloma, MDS/MPNs). Demonstrated track record of productive clinical and translational cancer research. Proven success in obtaining external peer‑reviewed funding. Eligibility for appointment at the rank of associate professor or professor at the Zucker School of Medicine. Active or eligible for medical licensure in New York State. We invite interested candidates to send CV and cover letter to Monday‑Friday 9 a.m. - 5 p.m. Eastern time. #J-18808-Ljbffr